Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Takafumi Minato"'
Autor:
Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato, Satoru Nirasawa, Masamitsu N. Asaka, Mayumi Niiyama, Masaki Imai, Akihiko Uda, Jasper Fuk-Woo Chan, Saori Takahashi, Jianbo An, Akari Saku, Ryota Nukiwa, Daichi Utsumi, Maki Kiso, Atsuhiro Yasuhara, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Yuji Fujino, Satoru Motoyama, Satoshi Nagata, Josef M. Penninger, Haruhiko Kamada, Kwok-Yung Yuen, Wataru Kamitani, Ken Maeda, Yoshihiro Kawaoka, Yasuhiro Yasutomi, Yumiko Imai, Keiji Kuba
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Endogenous ACE2 is a receptor for SARS-CoV-2 and a recombinant soluble ACE2 protein can inhibit SARS-CoV-2 infection acting as a decoy. Here the authors show that B38-CAP, an ACE2-like enzyme but not a decoy for the virus, is protective against SARS-
Externí odkaz:
https://doaj.org/article/37a0f877c7f0425f889b230ea8fdf522
Autor:
Takafumi Minato, Satoru Nirasawa, Teruki Sato, Tomokazu Yamaguchi, Midori Hoshizaki, Tadakatsu Inagaki, Kazuhiko Nakahara, Tadashi Yoshihashi, Ryo Ozawa, Saki Yokota, Miyuki Natsui, Souichi Koyota, Taku Yoshiya, Kumiko Yoshizawa-Kumagaye, Satoru Motoyama, Takeshi Gotoh, Yoshikazu Nakaoka, Josef M. Penninger, Hiroyuki Watanabe, Yumiko Imai, Saori Takahashi, Keiji Kuba
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
The enzyme ACE2 is involved in cardiac pathology and can counteract heart failure and other cardio-pulmonary diseases. Here the authors show that bacteria produce an ACE2-like enzyme that is effective in suppressing cardiac hypertrophy and fibrosis i
Externí odkaz:
https://doaj.org/article/d26136e7b956463b9d355114f88c8f40
Autor:
Takafumi Minato, Tomokazu Yamaguchi, Midori Hoshizaki, Satoru Nirasawa, Jianbo An, Saori Takahashi, Josef M Penninger, Yumiko Imai, Keiji Kuba
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0270920 (2022)
Angiotensin-converting enzyme 2 (ACE2) is the carboxypeptidase to degrade angiotensin II (Ang II) to angiotensin 1-7 (Ang 1-7) and improves the pathologies of cardiovascular disease and acute respiratory distress syndrome (ARDS)/acute lung injury. B3
Externí odkaz:
https://doaj.org/article/e0e9f7bbbeab446c833a438f989f5bdb
Autor:
Daichi Utsumi, Akari Saku, Yoshihiro Kawaoka, Kwok-Yung Yuen, Chris Chung-Sing Chan, Satoru Motoyama, Saori Takahashi, Jasper Fuk-Woo Chan, Jianbo An, Takafumi Minato, Satoshi Nagata, Vincent Kwok-Man Poon, Masaki Imai, Keiji Kuba, Maki Kiso, Midori Hoshizaki, Atsuhiro Yasuhara, Josef M. Penninger, Tomokazu Yamaguchi, Ken Maeda, Yasuhiro Yasutomi, Yumiko Imai, Haruhiko Kamada, Mayumi Niiyama, Akihiko Uda, Ryota Nukiwa, Masamitsu N Asaka, Satoru Nirasawa, Wataru Kamitani, Yuji Fujino
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Nature Communications
Nature Communications
Angiotensin-converting enzyme 2 (ACE2) is a receptor for cell entry of SARS-CoV-2, and recombinant soluble ACE2 protein inhibits SARS-CoV-2 infection as a decoy. ACE2 is a carboxypeptidase that degrades angiotensin II, thereby improving the pathologi
Autor:
Takafumi Minato, Midori Hoshizaki, Tomokazu Yamaguchi, Jianbo An, Mayumi Niiyama, Satoru Nirasawa, Masamitsu N Asaka, Jasper Fuk-Woo Chan, Masaki Imai, Saori Takahashi, Daichi Utsumi, Vincent Kwok-Man Poon, Atsuhiro Yasuhara, Chris Chung-Sing Chan, Satoru Motoyama, Satoshi Nagata, Josef M. Penninger, Haruhiko Kamada, Kwok-Yung Yuen, Yoshihiro Kawaoka, Yasuhiro Yasutomi, Yumiko Imai, Keiji Kuba
Angiotensin-converting enzyme 2 (ACE2) is a receptor for cell entry of SARS-CoV-2, and recombinant soluble ACE2 protein inhibits SARS-CoV-2 infection as a decoy. ACE2 is the carboxypeptidase to degrade angiotensin II (Ang II) to angiotensin 1-7 and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0e02e2d0cbbc16f2e837216be9006da
https://doi.org/10.21203/rs.3.rs-124634/v1
https://doi.org/10.21203/rs.3.rs-124634/v1
Autor:
Saori Takahashi, Takafumi Minato, Yumiko Imai, Keiji Kuba, Tadashi Yoshihashi, Yoshikazu Nakaoka, Midori Hoshizaki, Teruki Sato, Hiroyuki Watanabe, Satoru Nirasawa, Tadakatsu Inagaki, Kazuhiko Nakahara, Takeshi Gotoh, Josef M. Penninger, Taku Yoshiya, Satoru Motoyama, Saki Yokota, Miyuki Natsui, Tomokazu Yamaguchi, Kumiko Yoshizawa-Kumagaye, Ryo Ozawa, Souichi Koyota
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Nature Communications, 11:1058
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Nature Communications, 11:1058
Angiotensin-converting enzyme 2 (ACE2) is critically involved in cardiovascular physiology and pathology, and is currently clinically evaluated to treat acute lung failure. Here we show that the B38-CAP, a carboxypeptidase derived from Paenibacillus
Autor:
Tomokazu Yamaguchi, Takafumi Minato, Midori Hoshizaki, Satoru Nirasawa, Jianbo An, Saori Takahashi, Yumiko Imai, Keiji Kuba
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 96:YIA04-3
Autor:
Tomokazu Yamaguchi, Midori Hoshizaki, Takafumi Minato, Satoru Nirasawa, Masamitsu Asaka, Mayumi Niiyama, Jianbo An, Daichi Utsumi, Satoshi Nagata, Haruhiko Kamada, Wataru Kamitani, Yoshihiro Kawaoka, Yasuhiro Yasutomi, Yumiko Imai, Keiji Kuba
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 95:2-O
Autor:
Tsuyoshi Isojima, Takafumi Minato, Hiroko Kodama, Hitomi Asakura, Yuko Hino, Kyoko Nomura, Haruko Hiraike, Ayaka Aihara
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 16, Iss 18, p 3315 (2019)
Volume 16
Issue 18
International Journal of Environmental Research and Public Health, Vol 16, Iss 18, p 3315 (2019)
Volume 16
Issue 18
This study examined whether maternal nutritional intake and breast milk macronutrient content influence the weight of breastfed infants. We investigated 129 healthy mothers with singleton babies born from July 2016 to December 2017 in a university ho
Autor:
Midori Hoshizaki, Yumiko Imai, Satoru Nirasawa, Masaki Imai, Yoshihiro Kawaoka, Yasuhiro Yasutomi, Takafumi Minato, Saori Takahashi, Satoshi Nagata, Daichi Utsumi, Jianbo An, Haruhiko Kamada, Tomokazu Yamaguchi, Masamitsu N Asaka, Mayumi Niiyama, Keiji Kuba
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:2-P2